1.11
price up icon0.91%   0.01
 
loading
Synlogic Inc stock is traded at $1.11, with a volume of 26,483. It is up +0.91% in the last 24 hours and down -33.93% over the past month. Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
See More
Previous Close:
$1.10
Open:
$1.11
24h Volume:
26,483
Relative Volume:
0.61
Market Cap:
$12.99M
Revenue:
$3.37M
Net Income/Loss:
$-57.28M
P/E Ratio:
-0.1032
EPS:
-10.7522
Net Cash Flow:
$-51.83M
1W Performance:
+7.77%
1M Performance:
-33.93%
6M Performance:
-9.76%
1Y Performance:
-26.97%
1-Day Range:
Value
$1.11
$1.13
1-Week Range:
Value
$1.03
$1.2016
52-Week Range:
Value
$0.898
$1.96

Synlogic Inc Stock (SYBX) Company Profile

Name
Name
Synlogic Inc
Name
Phone
617-659-2802
Name
Address
PO BOX 30, WINCHESTER, MA
Name
Employee
1
Name
Twitter
@synlogic_tx
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
SYBX's Discussions on Twitter

Compare SYBX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
SYBX
Synlogic Inc
1.11 12.87M 3.37M -57.28M -51.83M -10.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.04 113.14B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
741.29 78.49B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
877.94 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
397.55 54.51B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
197.01 41.64B 447.02M -1.18B -906.14M -6.1812

Synlogic Inc Stock (SYBX) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-24-21 Upgrade Oppenheimer Perform → Outperform
Aug-21-19 Downgrade Oppenheimer Outperform → Perform
Apr-30-19 Initiated Jefferies Buy
Dec-13-18 Initiated Chardan Capital Markets Buy
Mar-19-18 Initiated H.C. Wainwright Buy
Jan-29-18 Initiated Piper Jaffray Overweight
View All

Synlogic Inc Stock (SYBX) Latest News

pulisher
Dec 12, 2025

Synlogic Inc Stock Analysis and ForecastVolume Spike Alerts & Outperform the Market with Aggressive Picks - earlytimes.in

Dec 12, 2025
pulisher
Dec 12, 2025

Is Dredging Corporation of India Limited a Top Growth Stock to Watch in YEAR - earlytimes.in

Dec 12, 2025
pulisher
Dec 05, 2025

Get in on Synlogic Inc’s (SYBX) buy-in window today! - Setenews

Dec 05, 2025
pulisher
Dec 05, 2025

Will Synlogic Inc. stock benefit from AI adoptionQuarterly Risk Review & Safe Capital Growth Stock Tips - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

How supply chain issues affect Synlogic Inc. stock2025 Risk Factors & Safe Capital Allocation Plans - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

Can Synlogic Inc. stock maintain operating margins2025 Short Interest & High Return Trade Guides - Newser

Dec 03, 2025
pulisher
Nov 27, 2025

Can Synlogic Inc. stock reach $100 price target2025 Momentum Check & Capital Protection Trade Alerts - BỘ NỘI VỤ

Nov 27, 2025
pulisher
Nov 27, 2025

Nasdaq notifies Synlogic of potential delisting over public shell status By Investing.com - Investing.com Australia

Nov 27, 2025
pulisher
Nov 27, 2025

Synlogic Challenges Nasdaq Delisting Notice - MSN

Nov 27, 2025
pulisher
Nov 26, 2025

Will Synlogic Inc. stock benefit from infrastructure spendingJuly 2025 Momentum & Comprehensive Market Scan Reports - moha.gov.vn

Nov 26, 2025
pulisher
Nov 26, 2025

Nasdaq notifies Synlogic of potential delisting over public shell status - Investing.com

Nov 26, 2025
pulisher
Nov 26, 2025

Synlogic receives letter from Nasdaq listing qualifications department on Nov 21SEC filing - marketscreener.com

Nov 26, 2025
pulisher
Nov 21, 2025

How Synlogic Inc. stock performs in weak economyJuly 2025 Technicals & Real-Time Volume Triggers - newser.com

Nov 21, 2025
pulisher
Nov 19, 2025

Is Synlogic Inc. stock a smart buy before Fed meetingEntry Point & Risk Managed Investment Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Synlogic Inc. stock maintain growth trajectory2025 Sector Review & Weekly High Conviction Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Synlogic Inc. stock sustain high P E ratiosJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What Wall Street predicts for Synlogic Inc. stock priceShort Setup & Capital Efficiency Focused Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Synlogic Inc. stock supported by strong cash flowsEarnings Overview Summary & Free High Return Stock Watch Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Synlogic Inc. stock sustain revenue growthRisk Management & Weekly Top Performers Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 17, 2025

How institutional buying supports Synlogic Inc. stockSwing Trade & Daily Stock Trend Reports - newser.com

Nov 17, 2025
pulisher
Nov 16, 2025

Synlogic Inc. stock outlook for YEARMarket Performance Report & Precise Buy Zone Tips - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

How Synlogic Inc. stock reacts to oil prices2025 Price Momentum & Weekly High Return Stock Forecasts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Will breakout in Synlogic Inc. lead to full recovery2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com

Nov 15, 2025

Synlogic Inc Stock (SYBX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Synlogic Inc Stock (SYBX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Dooley Mary Beth
See Remarks below
Apr 02 '25
Sale
1.20
144
173
12,901
Dooley Mary Beth
See Remarks below
Feb 03 '25
Sale
1.33
2,107
2,802
13,045
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Cap:     |  Volume (24h):